Jubilant Life Sciences is seeking shareholders nod to raise up to ₹1,000 crore through issuance of non-convertible debentures (NCDs) on private placement basis. “In order to provide necessary flexibility regarding borrowings of the company in an optimal manner depending on the market conditions, the company proposes to offer, issue and allot redeemable NCDs up to ₹1,000 crore...,” Jubilant Life Sciences said in the notice to shareholders that it filed to the BSE. This fund raising could be done in one or more series/tranches during a period of one year from the date of passing the resolution. Shares of Jubilant Life Sciences climbed 2.15 per cent at Rs 669.05 on the BSE

Uniply Industries Ltd has informed BSE that the Board of Directors has allotted 29.91 lakh new fully paid-up equity shares of ₹10 each at ₹204.62 a share on preferential basis to promoter and non-Promoter of the company on November 24. Pursuant to the allotment, the paid-up equity capital of the company has increased from ₹20.91 crore to ₹23.90 crore . The stock of Uniply Industries gained 3.4 per cent at ₹226.20 on the NSE.

Gufic Biosciences on Friday said its board has approved a scheme of amalgamation of Gufic Stridden Bio-Pharma with itself. The transaction is a related party transaction, it added. Post merger, the shareholders of the transferor company (subsidiary) would be issued shares of the transferee company (Gufic Bio) based on the valuation report from independent chartered accountant, it said. The stock of Gufic Biosciences closed at ₹46, up 0.66 per cent on the BSE.

Related Topics
comment COMMENT NOW